HIV-protease inhibitors potentiate the activity of carfilzomib in triple-negative breast cancer. Besse A, Sedlarikova L, Buechler L, Kraus M, et al. Br J Cancer 2024 Jul 5. doi: 10.1038/s41416-024-02774.

Read + Share

Amedeo Smart

Independent Medical Education

Besse A, Sedlarikova L, Buechler L, Kraus M, et al. HIV-protease inhibitors potentiate the activity of carfilzomib in triple-negative breast cancer. Br J Cancer 2024 Jul 5. doi: 10.1038/s41416-024-02774.
PMID: 38969867